MEK inhibitor may be effective for prevention of malignant transformation in premalignant lesion through RAS‐MEK1/2‐ ERK1/2 signaling pathway as well as lung adenocarcinoma chemoprevention. This evidence concerns the gene MAP2K1 and lung adenocarcinoma.